Effect of gamma-hydroxybutyrate on central dopamine release in vivo. A microdialysis study in awake and anesthetized animals

Biochemical Pharmacology
S G Howard, J J Feigenbaum

Abstract

gamma-Hydroxybutyrate (GHB) is generally considered to be an inhibitor of striatal dopamine (DA) release. However, a number of recent reports and at least one major review suggest that GHB enhances rather than inhibits striatal DA release. To examine this discrepancy, the effect of GHB on striatal DA release was monitored for 2 hr by microdialysis in awake and urethane-anesthetized rats. GHB (500 mg/kg, i.p.) significantly inhibited striatal DA release in conscious animals. However, anesthetic pretreatment completely abolished the inhibitory effect of GHB on DA release. In urethane-anesthetized animals, intraperitoneal injections of GHB resulted in a dialysis DA output that was the same as basal and saline control levels for all but the last three intervals where DA release was elevated slightly. In contrast to the intraperitoneal route, subcutaneous injections of GHB in anesthetized animals produced significant elevations of DA release above baseline levels. The increases ranged from 125 to 133% of basal levels. These results indicate that while GHB enhances striatal DA release in anesthetized animals, it inhibits rather than enhances this release in awake animals. This would explain why GHB induces an inhibition of DA-release...Continue Reading

References

Aug 1, 1979·European Journal of Pharmacology·C F Van ValkenburgA Wijling
Nov 15, 1978·European Journal of Pharmacology·A M Di GiulioF Ponzio
Jan 1, 1976·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·R H Roth
Jan 1, 1976·Journal of Neural Transmission·K MenonO Hornykiewicz
Aug 10, 1990·European Journal of Pharmacology·D E Walters, S G Howard
Jan 1, 1989·Neuroscience and Biobehavioral Reviews·M Mamelak
Feb 1, 1988·Canadian Journal of Physiology and Pharmacology·D W Clow, K Jhamandas
Apr 1, 1972·British Journal of Pharmacology·G Bustos, R H Roth
Sep 1, 1972·British Journal of Pharmacology·G Bustos, R H Roth
Apr 13, 1984·European Journal of Pharmacology·D A BergstromJ R Walters
Sep 1, 1996·Progress in Neurobiology·J J Feigenbaum, S G Howard

❮ Previous
Next ❯

Citations

Jan 20, 2004·European Journal of Pharmacology·Rajkumar J SevakWouter Koek
Mar 25, 1998·Pharmacology, Biochemistry, and Behavior·M C MartellottaW Fratta
Jul 13, 2000·Brain Research. Molecular Brain Research·M P CastelliG L Gessa
Apr 12, 2001·Drug and Alcohol Dependence·K L Nicholson, R L Balster
Jun 28, 2000·Alcohol·G P GallowayD E Smith
Jun 28, 2000·Alcohol·M MonciniP F Mannaioni
Jan 1, 1997·Journal of Toxicology. Clinical Toxicology·G Tunnicliff
Jun 16, 2015·Frontiers in Neurology·Jimmy J FraigneJohn H Peever
Mar 18, 2009·The International Journal of Neuropsychopharmacology·Carmen PedrazaJosé Francisco Navarro
Nov 20, 2004·Journal of Cardiovascular Pharmacology·Alissa R HicksKurt J Varner
Aug 5, 2010·Journal of Neurochemistry·Fatima A NasrallahCaroline D Rae
Dec 2, 2006·The Journal of Pharmacology and Experimental Therapeutics·Joseph J Raybon, Kathleen M K Boje
Jan 8, 2016·Medicinal Research Reviews·Michel MaitreAyikoe G Mensah-Nyagan
Jul 28, 2020·The International Journal of Neuropsychopharmacology·Enzo Javier Pérez-ValenzuelaJosé Antonio Fuentealba Evans
Aug 10, 2004·Toxicological Reviews·C Guin Ting WongO Carter Snead
Oct 18, 2000·Journal of Neurochemistry·O C Snead
Apr 27, 2021·Human Psychopharmacology·Stephen J KishIsabelle Boileau
Jun 19, 2004·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Ho-Leung FungSun-Mi Fung

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.